Cobalt-57 bleomycin for imaging head and neck tumors

J. M. Woolfenden, David S Alberts, J. N. Hall, D. D. Patton

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cobalt-57 bleomycin was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.

Original languageEnglish (US)
Pages (from-to)1652-1657
Number of pages6
JournalCancer
Volume43
Issue number5
StatePublished - 1979

Fingerprint

Neck
Head
Neoplasms
Head and Neck Neoplasms
cobalt bleomycin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Woolfenden, J. M., Alberts, D. S., Hall, J. N., & Patton, D. D. (1979). Cobalt-57 bleomycin for imaging head and neck tumors. Cancer, 43(5), 1652-1657.

Cobalt-57 bleomycin for imaging head and neck tumors. / Woolfenden, J. M.; Alberts, David S; Hall, J. N.; Patton, D. D.

In: Cancer, Vol. 43, No. 5, 1979, p. 1652-1657.

Research output: Contribution to journalArticle

Woolfenden, JM, Alberts, DS, Hall, JN & Patton, DD 1979, 'Cobalt-57 bleomycin for imaging head and neck tumors', Cancer, vol. 43, no. 5, pp. 1652-1657.
Woolfenden JM, Alberts DS, Hall JN, Patton DD. Cobalt-57 bleomycin for imaging head and neck tumors. Cancer. 1979;43(5):1652-1657.
Woolfenden, J. M. ; Alberts, David S ; Hall, J. N. ; Patton, D. D. / Cobalt-57 bleomycin for imaging head and neck tumors. In: Cancer. 1979 ; Vol. 43, No. 5. pp. 1652-1657.
@article{878a75d941424d38901c4647c0995b7b,
title = "Cobalt-57 bleomycin for imaging head and neck tumors",
abstract = "Cobalt-57 bleomycin was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82{\%}); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18{\%}) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.",
author = "Woolfenden, {J. M.} and Alberts, {David S} and Hall, {J. N.} and Patton, {D. D.}",
year = "1979",
language = "English (US)",
volume = "43",
pages = "1652--1657",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Cobalt-57 bleomycin for imaging head and neck tumors

AU - Woolfenden, J. M.

AU - Alberts, David S

AU - Hall, J. N.

AU - Patton, D. D.

PY - 1979

Y1 - 1979

N2 - Cobalt-57 bleomycin was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.

AB - Cobalt-57 bleomycin was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.

UR - http://www.scopus.com/inward/record.url?scp=0018747894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018747894&partnerID=8YFLogxK

M3 - Article

C2 - 87253

AN - SCOPUS:0018747894

VL - 43

SP - 1652

EP - 1657

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -